MétaCan
Menu
← Back to cohort
Record W4401937484 · doi:10.1101/2024.08.26.24312580

Adaptive Deep Brain Stimulation in Parkinson’s Disease: A Delphi Consensus Study

2024· preprint· en· W4401937484 on OpenAlexaff
Matteo Guidetti, Tommaso Bocci, Marta De Pedro Del Álamo, Günther Deuschl, Alfonso Fasano, Raúl Martínez‐Fernández, Carmen Gasca‐Salas, Clement Hamani, Joachim K. Krauss, Andrea A. Kühn, Patricia Limousin, Simon Little, Andrés M. Lozano, Natale Vincenzo Maiorana, Sara Marceglia, Michael S. Okun, Serena Oliveri, Jill L. Ostrem, Emma Scelzo, Alfons Schnitzler, Phillip A. Starr, Yasin Temel, Lars Timmermann, Gerd Tinkhauser, Veerle Visser‐Vandewalle, Jens Volkmann, Alberto Priori

Bibliographic record

VenuemedRxiv · 2024
Typepreprint
Languageen
FieldMedicine
TopicNeurological disorders and treatments
Canadian institutionsSunnybrook Health Science CentreToronto Western HospitalUniversity of TorontoHealth Sciences CentreUniversity Health Network
FundersDeutsche Parkinson VereinigungNeuraxpharmAcorda TherapeuticsNational Institutes of HealthBoston Scientific CorporationDeutsche ForschungsgemeinschaftTeva Pharmaceutical Industries
KeywordsDeep brain stimulationDelphi methodLikert scaleParkinson's diseaseRating scaleDelphiMotor symptomsClinical PracticePhysical medicine and rehabilitationPsychologyMedicineComputer scienceDiseasePhysical therapyArtificial intelligence

Abstract

fetched live from OpenAlex

Importance: If history teaches, as cardiac pacing moved from fixed-rate to on-demand delivery in in 80s of the last century, there are high probabilities that closed-loop and adaptive approaches will become, in the next decade, the natural evolution of conventional Deep Brain Stimulation (cDBS). However, while devices for aDBS are already available for clinical use, few data on their clinical application and technological limitations are available so far. In such scenario, gathering the opinion and expertise of leading investigators worldwide would boost and guide practice and research, thus grounding the clinical development of aDBS. Observations: We identified clinical and academically experienced DBS clinicians (n=21) to discuss the challenges related to aDBS. A 5-point Likert scale questionnaire along with a Delphi method was employed. 42 questions were submitted to the panel, half of them being related to technical aspects while the other half to clinical aspects of aDBS. Experts agreed that aDBS will become clinical practice in 10 years. In the present scenario, although the panel agreed that aDBS applications require skilled clinicians and that algorithms need to be further optimized to manage complex PD symptoms, consensus was reached on aDBS safety and its ability to provide a faster and more stable treatment response than cDBS, also for tremor-dominant Parkinson's disease patients and for those with motor fluctuations and dyskinesias. Conclusions and Relevance: Despite the need of further research, the panel concluded that aDBS is safe, promises to be maximally effective in PD patients with motor fluctuation and dyskinesias and therefore will enter into the clinical practice in the next years, with further research focused on algorithms and markers for complex symptoms.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.158
metaresearch head score (Gemma)0.114
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.158
Threshold uncertainty score0.837

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1580.114
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.002
Science and technology studies0.0040.004
Scholarly communication0.0030.004
Open science0.0030.012
Research integrity0.0040.004
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.322
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designQualitative
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2024
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicNeurological disorders and treatments→French-language works237,207→